Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Hong-gui Xu"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Purpose To explore the outcome and prognostic factors between inv(16) and t(8;21) disrupt core binding factor (CBF) in acute myeloid leukemia (AML). Methods The clinical characteristic, probability of achieving complete remission (CR), overa
Externí odkaz:
https://doaj.org/article/bf1c9252028842ca9314938850774aff
Autor:
Kun-yin Qiu, Dun-hua Zhou, Xiong-yu Liao, Ke Huang, Yang Li, Hong-gui Xu, Wen-jun Weng, Lu-hong Xu, Jian-pei Fang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Purpose To evaluate the prognostic factors and outcome for acute lymphoblastic leukemia (ALL) in children with MLL rearrangement (MLL-r). Methods A total of 124 pediatric patients who were diagnosed with ALL were classified into two groups b
Externí odkaz:
https://doaj.org/article/05242078cda84627a5242240d75eeb76
Autor:
Xin-Yu Li, Li-Ping Zhan, Dian-Dian Liu, Xia-Wei Han, Han Chen, Zheng-Zhou Wu, Yin Wang, Li-Ping Que, Xiao-Jun Wu, Su Liu, Kai-Mei Wang, Shao-Liang Huang, Jian-Pei Fang, Ke Huang, Hong-Gui Xu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Umbilical cord blood transplantation (UCBT) from unrelated donors is one of the successful treatments for acute leukemia in childhood. The most frequent side effect of UCBT is peri-engraftment syndrome (PES), which is directly ass
Externí odkaz:
https://doaj.org/article/f2f03d0f53b545db8cd64c21c2026643
Autor:
Xin-Yu Li, Xia-Wei Han, Ke Huang, Ya-Ting Zhang, Hong-Gui Xu, Dun-Hua Zhou, Lu-Hong Xu, Jian-Pei Fang
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundThe long-term overall survival of children with T-cell acute lymphoblastic leukemia (T-ALL) is limited to approximately 80–85% because of a high incidence of relapse after achieving remission with intensive chemotherapy and hematopoietic
Externí odkaz:
https://doaj.org/article/2ef0cf310e9a4881b0a5792c1b6f31ff
Autor:
Xin-Yu Li, Jia-Qiang Li, Xue-Qun Luo, Xue-Dong Wu, Xin Sun, Hong-Gui Xu, Chang-Gang Li, Ri-Yang Liu, Xiao-Fei Sun, Hui-Qin Chen, Yu-Deng Lin, Chi-kong LI, Jian-Pei Fang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background The prognosis of childhood acute lymphoblastic leukemia (ALL) is optimistic with a 5-year event-free survival (EFS) rate of 70–85%. However, the major causes of mortality are chemotherapy toxicity, infection and relapse. The Gua
Externí odkaz:
https://doaj.org/article/598bd0c56f2e463e91357af329b8584c
Autor:
Kun-yin Qiu, Hong-gui Xu, Xue-qun Luo, Hui-rong Mai, Ning Liao, Li-hua Yang, Min-cui Zheng, Wu-qing Wan, Xue-dong Wu, Ri-yang Liu, Qi-wen Chen, Hui-qin Chen, Xiao-fei Sun, Hua Jiang, Xing-jiang Long, Guo-hua Chen, Xin-yu Li, Chang-gang Li, Li-bin Huang, Ya-yun Ling, Dan-na Lin, Chuan Wen, Wen-yong Kuang, Xiao-qin Feng, Zhong-lv Ye, Bei-yan Wu, Xiang-lin He, Qiao-ru Li, Li-na Wang, Xian-ling Kong, Lu-hong Xu, Chi-kong Li, Jian-pei Fang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeTo analyzed the outcome of ETV6/RUNX1-positive pediatric acute B lymphoblastic leukemia (B-ALL) with the aim of identifying prognostic value.MethodA total of 2,530 pediatric patients who were diagnosed with B-ALL were classified into two group
Externí odkaz:
https://doaj.org/article/348375087ff341a19f0e6f40c3406e09
Autor:
Boris S. Morozov, Aleksandr S. Oshchepkov, Insa Klemt, Aleksandr M. Agafontsev, Swathi Krishna, Frank Hampel, Hong-Gui Xu, Andriy Mokhir, Dirk Guldi, Evgeny Kataev
Publikováno v:
JACS Au. 3:964-977
Autor:
Yang Li, Dun-Hua Zhou, Wen-Jun Weng, Jian-Pei Fang, Lu-Hong Xu, Hong-Gui Xu, Kunyin Qiu, Ruohao Wu, Ke Huang, Xiong-yu Liao
Publikováno v:
British Journal of Clinical Pharmacology. 87:2023-2031
AIMS The purpose of this study is to examine the safety and efficacy of eltrombopag as first-line treatment for thrombocytopenia among paediatric patients after haematopoietic stem cell transplantation (HSCT). METHODS Forty-three childhood patients w
Autor:
Hülya Gizem Özkan, Vanrajsinh Thakor, Hong‐Gui Xu, Galyna Bila, Rostyslav Bilyy, Daria Bida, Martin Böttcher, Dimitrios Mougiakakos, Rainer Tietze, Andriy Mokhir
Publikováno v:
Chemistry – A European Journal. 28
Elevated levels of reactive oxygen species (ROS) and deficient mitochondria are two weak points of cancer cells. Their simultaneous targeting is a valid therapeutic strategy to design highly potent anticancer drugs. The remaining challenge is to limi